Morgan Stanley: Mixed Weekly Prescription Trends in U.S. Neurology Drugs
Morgan Stanley published its weekly prescription-tracking figures for select U.S. neurology medicines using IQVIA data for the week ending May 29. The data show modest year-over-year growth in the broader antipsychotic category and for several individual products, while week-over-week comparisons frequently show declines amid a holiday week. Rollin…